Characteristic | DS | SS | Between-group differences in change from baseline to 12 weeks | ||||||
---|---|---|---|---|---|---|---|---|---|
Baseline | 12 weeks | Baseline | 12 weeks | ||||||
M (SE) | M (SE) | M (SE) | M (SE) | M (SE) | 95% CI [LCI, UCI] | t a | df | p | |
Symptoms | |||||||||
MADRS (0-60) | 26.1 (1.0) | 14.8 (1.1) | 24.7 (1.0) | 20.5 (1.2) | 7.1 (1.6) | 3.9, 10.4 | 4.38 | 60.7 | <.001 |
HADS – (D) (0-21) | 10.0 (0.6) | 5.3 (0.7) | 9.2 (0.6) | 6.8 (0.7) | 2.3 (1.1) | 0.2, 4.4 | 2.20 | 55.1 | .032 |
HADS – (A) (0-21) | 12.1 (0.6) | 8.4 (0.6) | 11.2 (0.6) | 9.5 (0.7) | 2.0 (0.9) | 0.2, 3.9 | 2.19 | 59.0 | .033 |
Mood | |||||||||
POMS (-32–200) | 54.5 (6.0) | 30.3 (6.5) | 40.9 (5.8) | 32.1 (6.7) | 15.4 (9.9) | -4.6, 35.3 | 1.56 | 43.5 | .127 |
Self-efficacy | |||||||||
GSE (10-40) | 24.6 (1.0) | 28.1 (1.0) | 25.7 (1.0) | 26.7 (1.1) | -2.4 (1.6) | -5.7, 0.9 | -1.44 | 59.0 | .156 |
Wellbeing | |||||||||
WHO-5 (0-25) | 6.9 (0.8) | 12.3 (0.9) | 6.7 (0.8) | 10.3 (1.0) | -1.8 (1.7) | -5.2, 1.6 | -1.04 | 62.0 | .304 |
Anthropometry | |||||||||
BMI | 30.0 (1.4) | 29.9 (1.4) | 29.0 (1.4) | 29.1 (1.4) | 0.15 (0.27) | -0.4, 0.7 | 0.56 | 47.0 | .579 |
Physical activity (IPAQ scores) | 2307.7 (664.8) | 2251.3 (645.9) | 2509.4 (636.3) | 2892.2 (636.3) | 439.3 (1097.6) | -1757.2, 2635 | 0.40 | 58.9 | .690 |
Diet | |||||||||
ModiMedDiet (0-120) | 36.2 (2.5) | 55.1 (2.8) | 47.3 (2.6) | 45.4 (2.9) | -20.7 (4.3) | -20.7, -12.1 | -4.78 | 55.62 | <.001 |
Biomarkers | |||||||||
Glucose (mmol/L) | 4.5 (0.5) | 4.7 (5.5) | 5.4 (0.5) | 5.5 (0.6) | -0.1 (4.3) | -0.9, 0.8 | -0.10 | 48.5 | .919 |
Cholesterol (mmol/L) | 4.9 (0.2) | 4.8 (0.2) | 5.5 (0.2) | 5.2 (0.2) | -0.2 (0.2) | -0.5, 0.2 | -1.08 | 47.7 | .287 |
Triglycerides (mmol/L) | 1.3 (0.2) | 1.2 (0.2) | 1.4 (0.2) | 1.5 (0.2) | 0.2 (0.2) | -0.3, 0.7 | 0.88 | 53.4 | .386 |
HDL cholesterol (mmol/L) | -1.5 (0.1) | 1.5 (0.1) | 1.4 (0.1) | 1.3 (0.1) | -0.1 (0.1) | -0.2, 0.1 | -1.11 | 47.7 | .272 |
LDL cholesterol (mmol/L) | 2.9 (0.2) | 2.8 (0.1) | 3.4 (0.2) | 3.2 (0.2) | -0.1 (0.2) | -0.4, 0.3 | -0.48 | 47.1 | .636 |
Total saturates (% FA) | 35.7 (0.5) | 36.6 (0.5) | 35.6 (0.5) | 38.1 (0.6) | 1.6 (1.0) | -0.5, 3.6 | 1.54 | 62.1 | .128 |
Total monounsaturates (% FA) | 23.2 (0.4) | 22.2 (0.5) | 22.8 (0.4) | 23.2 (0.6) | 1.4 (0.8) | -0.3, 3.1 | 1.69 | 55.4 | .096 |
Total polyunsaturates (% FA) | 41.1 (0.7) | 41.3 (0.8) | 41.6 (0.7) | 38.6 (0.9) | -3.1 (1.3) | -5.7, 0.5 | -2.41 | 54.9 | .019 |
n6 (% PUFA) | 14.6 (0.4) | 14.5 (0.4) | 14.3 (0.4) | 12.8 (0.5) | -1.4 (0.8) | -3.0, 0.3 | -1.69 | 62.1 | .096 |
n3 (% PUFA) | 6.9 (0.3) | 6.8 (0.3) | 6.5 (0.3) | 7.2 (0.4) | 0.9 (0.6) | -0.3, 2.1 | 1.57 | 57.8 | .123 |